Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects

被引:2
|
作者
David Czock
Frieder Keller
机构
[1] University Hospital Ulm,Division of Nephrology, Medical Department
关键词
Pharmacokinetics; Pharmacodynamics; PK–PD modeling; Antimicrobials; Antibiotics; Resistance; Simulation;
D O I
暂无
中图分类号
学科分类号
摘要
Mathematical modeling of drug effects maximizes the information gained from an experiment, provides further insight into the mechanisms of drug effects, and allows for simulations in order to design studies or even to derive clinical treatment strategies. We reviewed modeling of antimicrobial drug effects and show that most of the published mathematical models can be derived from one common mechanism-based PK–PD model premised on cell growth and cell killing processes. The general sigmoid Emax model applies to cell killing and the various parameters can be related to common pharmacodynamics, which enabled us to synthesize and compare the different parameter estimates for a total of 24 antimicrobial drugs from published literature. Furthermore, the common model allows the parameters of these models to be related to the MIC and to a common set of PK–PD indices. Theoretically, a high Hill coefficient and a low maximum kill rate indicate so-called time-dependent antimicrobial effects, whereas a low Hill coefficient and a high maximum kill rate indicate so-called concentration-dependent effects, as illustrated in the garenoxacin and meropenem examples. Finally, a new equation predicting the time to microorganism eradication after repeated drug doses was derived that is based on the area under the kill-rate curve.
引用
收藏
页码:727 / 751
页数:24
相关论文
共 50 条
  • [31] Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling
    Elizabeth C. M. de Lange
    Paulien G. M. Ravenstijn
    Dorien Groenendaal
    Tamara J. van Steeg
    [J]. The AAPS Journal, 7
  • [32] Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment
    Harrold, John M.
    Abraham, Anson K.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (02) : 141 - 151
  • [33] Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans
    Venisse, Nicolas
    Gregoire, Nicolas
    Marliat, Manuella
    Couet, William
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 937 - 943
  • [34] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats
    Kobuchi, Shinji
    Katsuyama, Yosuke
    Ito, Yukako
    [J]. XENOBIOTICA, 2020, 50 (02) : 146 - 153
  • [35] Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment
    John M. Harrold
    Anson K. Abraham
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2014, 41 : 141 - 151
  • [36] Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo
    Jonker, DM
    Visser, SAG
    van der Graaf, PH
    Voskuyl, RA
    Danhof, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) : 1 - 18
  • [37] Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Dopamine D2 Receptor Occupancy of Olanzapine in Rats
    Johnson, Martin
    Kozielska, Magdalena
    Reddy, Venkatesh Pilla
    Vermeulen, An
    Li, Cheryl
    Grimwood, Sarah
    de Greef, Rik
    Groothuis, Geny M. M.
    Danhof, Meindert
    Proost, Johannes H.
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (10) : 2490 - 2504
  • [38] Pharmacokinetic/pharmacodynamic modeling in drug development
    Sheiner, LB
    Steimer, JL
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 : 67 - 95
  • [39] Mechanism-Based Pharmacodynamic Modeling of the Interaction of Midazolam, Bretazenil, and Zolpidem with Ethanol
    Bert Tuk
    Toon van Gool
    Meindert Danhof
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2002, 29 : 235 - 250
  • [40] Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol
    Tuk, B
    van Gool, T
    Danhof, M
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2002, 29 (03) : 235 - 250